Tapewire

Nasdaq · USD

NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp

Export transactions ↓
Tapewire entity
7808
SEC CIK
0001500198
Parsed reports
227

Last 12 months

Inside the activity.

2 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202615
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 28, 2026 Filed Sep 8, 2026 12:31 UTC
Wambeke David J.Chief Business Officer
GrantOption to Purchase Common Stock · Derivative 35,000 $0.00 Strike: $1.77 $0.00
Disclosure

SEC source: 0001971798-26-000005 · primary_doc.xml · derivative · entry 2

Wambeke David J. · CIK 0001971798 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2036-08-27

F2 · derivative.exercise_date: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Read SEC document
August 28, 2026 Filed Aug 28, 2026 17:29 UTC
Johns Emily J.Chief Administrative Officer
GrantOption to Purchase Common Stock · Derivative 12,500 $0.00 Strike: $1.77 $0.00
Disclosure

SEC source: 0002067635-26-000002 · primary_doc.xml · derivative · entry 1

Johns Emily J. · CIK 0002067635 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-08-27

F1 · derivative.exercise_date: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Read SEC document
August 28, 2026 Filed Aug 28, 2026 17:04 UTC
Volker ChristopherChief Financial Officer
GrantOption to Purchase Common Stock · Derivative 35,000 $0.00 Strike: $1.77 $0.00
Disclosure

SEC source: 0002000429-26-000003 · primary_doc.xml · derivative · entry 1

Volker Christopher · CIK 0002000429 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2036-08-27

F1 · derivative.exercise_date: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Read SEC document
August 28, 2026 Filed Aug 28, 2026 17:00 UTC
Christianson MarkMarket Development Director
GrantOption to Purchase Common Stock · Derivative 12,500 $0.00 Strike: $1.77 $0.00
Disclosure

SEC source: 0001709738-26-000011 · primary_doc.xml · derivative · entry 1

Christianson Mark · CIK 0001709738 · Market Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-08-27

F1 · derivative.exercise_date: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Read SEC document
August 28, 2026 Filed Aug 28, 2026 20:57 UTC
Mertens SteveChief Technology Officer
GrantOption to Purchase Common Stock · Derivative 15,000 $0.00 Strike: $1.77 $0.00
Disclosure

SEC source: 0001772652-26-000006 · primary_doc.xml · derivative · entry 1

Mertens Steve · CIK 0001772652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2036-08-27

F1 · derivative.exercise_date: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Read SEC document
August 28, 2026 Filed Aug 28, 2026 20:51 UTC
Rosa David ADirector · CEO & President
GrantOption to Purchase Common Stock · Derivative 68,000 $0.00 Strike: $1.77 $0.00
Disclosure

SEC source: 0001540354-26-000006 · primary_doc.xml · derivative · entry 1

Rosa David A · CIK 0001540354 · Director · CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,000

Underlying: Common Stock · 68,000 shares

Expires 2036-08-27

F1 · derivative.exercise_date: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Read SEC document
August 27, 2026 Filed Sep 8, 2026 12:31 UTC
Wambeke David J.Chief Business Officer
PurchaseCommon Stock 33,333 $2.01 $66,999.33
Disclosure

SEC source: 0001971798-26-000005 · primary_doc.xml · nonDerivative · entry 1

Wambeke David J. · CIK 0001971798 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,999

F1 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $2.00 and $2.017 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:39 UTC
Christianson MarkMarket Development Director
SaleCommon Stock 10,000 $3.18 $31,773.00
Disclosure

SEC source: 0001709738-26-000010 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Market Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,692

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:46 UTC GrantOption to Purchase Common Stock · Derivative 26,036 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0002103204-26-000005 · primary_doc.xml · derivative · entry 2

Mills Jason Richard · CIK 0002103204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,036

Underlying: Common Stock · 26,036 shares

Expires 2036-04-02

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:46 UTC GrantCommon Stock 41,929 $0.00 $0.00
Disclosure

SEC source: 0002103204-26-000005 · primary_doc.xml · nonDerivative · entry 1

Mills Jason Richard · CIK 0002103204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,687

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:38 UTC GrantOption to Purchase Common Stock · Derivative 26,036 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001296853-26-000001 · primary_doc.xml · derivative · entry 2

MATHIESEN JEFFREY S · CIK 0001296853 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,036

Underlying: Common Stock · 26,036 shares

Expires 2036-04-02

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:38 UTC GrantCommon Stock 41,929 $0.00 $0.00
Disclosure

SEC source: 0001296853-26-000001 · primary_doc.xml · nonDerivative · entry 1

MATHIESEN JEFFREY S · CIK 0001296853 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,343

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:28 UTC
BUCKMAN PAULDirector
GrantOption to Purchase Common Stock · Derivative 26,036 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001215243-26-000004 · primary_doc.xml · derivative · entry 2

BUCKMAN PAUL · CIK 0001215243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,036

Underlying: Common Stock · 26,036 shares

Expires 2036-04-02

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:28 UTC
BUCKMAN PAULDirector
GrantCommon Stock 41,929 $0.00 $0.00
Disclosure

SEC source: 0001215243-26-000004 · primary_doc.xml · nonDerivative · entry 1

BUCKMAN PAUL · CIK 0001215243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,733

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:22 UTC GrantOption to Purchase Common Stock · Derivative 26,036 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001656026-26-000003 · primary_doc.xml · derivative · entry 2

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,036

Underlying: Common Stock · 26,036 shares

Expires 2036-04-02

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
April 03, 2026 Filed Apr 7, 2026 17:22 UTC GrantCommon Stock 41,929 $0.00 $0.00
Disclosure

SEC source: 0001656026-26-000003 · primary_doc.xml · nonDerivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,932

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 20:11 UTC
Christianson MarkBusiness Development Director
Tax withholdingCommon Stock 253 $0.78 $196.58
Disclosure

SEC source: 0001709738-26-000009 · primary_doc.xml · nonDerivative · entry 2

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,667

Read SEC document
March 31, 2026 Filed Apr 1, 2026 20:08 UTC
Mertens SteveChief Technology Officer
Tax withholdingCommon Stock 906 $0.78 $703.96
Disclosure

SEC source: 0001772652-26-000005 · primary_doc.xml · nonDerivative · entry 1

Mertens Steve · CIK 0001772652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,141

Read SEC document
March 31, 2026 Filed Apr 1, 2026 20:01 UTC
Rosa David ADirector · CEO and President
Tax withholdingCommon Stock 2,458 $0.78 $1,909.87
Disclosure

SEC source: 0001540354-26-000005 · primary_doc.xml · nonDerivative · entry 1

Rosa David A · CIK 0001540354 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,080,132

Read SEC document
March 30, 2026 Filed Apr 1, 2026 20:11 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 15,363 $0.74 $11,368.62
Disclosure

SEC source: 0001709738-26-000009 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,920

Read SEC document
March 13, 2026 Filed Mar 16, 2026 19:30 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 100 $0.80 $80.00
Disclosure

SEC source: 0001709738-26-000008 · primary_doc.xml · nonDerivative · entry 2

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,283

Read SEC document
March 12, 2026 Filed Mar 16, 2026 19:30 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 817 $0.80 $653.60
Disclosure

SEC source: 0001709738-26-000008 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,383

Read SEC document
March 11, 2026 Filed Mar 12, 2026 19:58 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 2,109 $0.80 $1,687.20
Disclosure

SEC source: 0001709738-26-000007 · primary_doc.xml · nonDerivative · entry 2

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,200

F2 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.80 and 0.805 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 10, 2026 Filed Mar 12, 2026 19:58 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 11,611 $0.80 $9,288.80
Disclosure

SEC source: 0001709738-26-000007 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,309

F1 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.80 and 0.8102 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 13:49 UTC
Wambeke David J.Chief Business Officer
GrantOption to Purchase Common Stock · Derivative 500,000 $0.00 Strike: $0.67 $0.00
Disclosure

SEC source: 0001971798-26-000002 · primary_doc.xml · derivative · entry 2

Wambeke David J. · CIK 0001971798 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2036-02-29

F1 · derivative.exercise_date: 25% will vest on March 1, 2027, and the remaining 75% will vest in 12 equal installments on the last day of each quarter beginning on March 31, 2027.

Read SEC document
March 01, 2026 Filed Mar 3, 2026 13:49 UTC
Wambeke David J.Chief Business Officer
PurchaseCommon Stock 1,000,000 $0.67 $670,400.00
Disclosure

SEC source: 0001971798-26-000002 · primary_doc.xml · nonDerivative · entry 1

Wambeke David J. · CIK 0001971798 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Read SEC document
February 18, 2026 Filed Feb 20, 2026 19:20 UTC
Christianson MarkBusiness Development Director
Tax withholdingCommon Stock 1,812 $0.68 $1,232.16
Disclosure

SEC source: 0001709738-26-000006 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,920

Read SEC document
February 18, 2026 Filed Feb 20, 2026 19:15 UTC
Rosa David ADirector · CEO and President
Tax withholdingCommon Stock 71,325 $0.68 $48,501.00
Disclosure

SEC source: 0001540354-26-000004 · primary_doc.xml · nonDerivative · entry 1

Rosa David A · CIK 0001540354 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,082,590

Read SEC document
February 18, 2026 Filed Feb 20, 2026 19:27 UTC
Mertens SteveChief Technology Officer
Tax withholdingCommon Stock 7,376 $0.68 $5,015.68
Disclosure

SEC source: 0001772652-26-000004 · primary_doc.xml · nonDerivative · entry 1

Mertens Steve · CIK 0001772652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,047

Read SEC document
December 31, 2025 Filed Jan 5, 2026 21:11 UTC
Christianson MarkBusiness Development Director
Tax withholdingCommon Stock 253 $0.76 $191.77
Disclosure

SEC source: 0001709738-26-000001 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,732

Read SEC document
December 31, 2025 Filed Jan 5, 2026 21:46 UTC
Mertens SteveChief Technology Officer
Tax withholdingCommon Stock 906 $0.76 $686.75
Disclosure

SEC source: 0001772652-26-000001 · primary_doc.xml · nonDerivative · entry 1

Mertens Steve · CIK 0001772652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,423

Read SEC document
December 31, 2025 Filed Jan 5, 2026 21:38 UTC
Rosa David ADirector · CEO and President
Tax withholdingCommon Stock 2,458 $0.76 $1,863.16
Disclosure

SEC source: 0001540354-26-000001 · primary_doc.xml · nonDerivative · entry 1

Rosa David A · CIK 0001540354 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,153,915

Read SEC document
December 18, 2025 Filed Jan 2, 2026 17:03 UTC GrantOption to purchase common stock · Derivative 4,806 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0002103204-26-000002 · primary_doc.xml · derivative · entry 2

Mills Jason Richard · CIK 0002103204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,806

Underlying: Common Stock · 4,806 shares

Expires 2035-12-18

F2 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
December 18, 2025 Filed Jan 2, 2026 17:03 UTC GrantCommon Stock 7,758 $0.00 $0.00
Disclosure

SEC source: 0002103204-26-000002 · primary_doc.xml · nonDerivative · entry 1

Mills Jason Richard · CIK 0002103204 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,758

F1 · shares: Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
September 30, 2025 Filed Oct 1, 2025 18:15 UTC
Christianson MarkBusiness Development Director
Tax withholdingCommon Stock 253 $0.89 $224.82
Disclosure

SEC source: 0001709738-25-000011 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,985

Read SEC document
September 30, 2025 Filed Oct 1, 2025 18:20 UTC
Mertens SteveChief Technology Officer
Tax withholdingCommon Stock 906 $0.89 $805.07
Disclosure

SEC source: 0001772652-25-000006 · primary_doc.xml · nonDerivative · entry 1

Mertens Steve · CIK 0001772652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,329

Read SEC document
September 30, 2025 Filed Oct 1, 2025 18:05 UTC
Rosa David ADirector · CEO and President
Tax withholdingCommon Stock 2,458 $0.89 $2,184.18
Disclosure

SEC source: 0001540354-25-000009 · primary_doc.xml · nonDerivative · entry 1

Rosa David A · CIK 0001540354 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,156,373

Read SEC document
September 05, 2025 Filed Sep 9, 2025 20:15 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 30,000 $0.74 $22,203.00
Disclosure

SEC source: 0001709738-25-000010 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 231,238

F1 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.7400 to $0.7518 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 16:22 UTC
Christianson MarkBusiness Development Director
Tax withholdingCommon Stock 253 $0.68 $171.53
Disclosure

SEC source: 0001709738-25-000008 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,238

Read SEC document
June 30, 2025 Filed Jul 2, 2025 14:58 UTC
Mertens SteveChief Technology Officer
Tax withholdingCommon Stock 906 $0.68 $614.27
Disclosure

SEC source: 0001540354-25-000007 · primary_doc.xml · nonDerivative · entry 1

Mertens Steve · CIK 0001772652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,235

Read SEC document
June 30, 2025 Filed Jul 2, 2025 14:42 UTC
Rosa David ADirector · CEO and President
Tax withholdingCommon Stock 2,458 $0.68 $1,666.52
Disclosure

SEC source: 0001540354-25-000006 · primary_doc.xml · nonDerivative · entry 1

Rosa David A · CIK 0001540354 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,158,831

Read SEC document
June 23, 2025 Filed Jun 25, 2025 19:47 UTC GrantOption to Purchase Common Stock · Derivative 50,000 $0.00 Strike: $0.66 $0.00
Disclosure

SEC source: 0001656026-25-000004 · primary_doc.xml · derivative · entry 1

MATHIESEN JEFFREY S · CIK 0001296853 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-06-23

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 19:42 UTC
BUCKMAN PAULDirector
GrantOption to Purchase Common Stock · Derivative 50,000 $0.00 Strike: $0.66 $0.00
Disclosure

SEC source: 0001656026-25-000003 · primary_doc.xml · derivative · entry 1

BUCKMAN PAUL · CIK 0001215243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-06-23

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
June 23, 2025 Filed Jun 25, 2025 19:34 UTC GrantOption to Purchase Common Stock · Derivative 50,000 $0.00 Strike: $0.66 $0.00
Disclosure

SEC source: 0001656026-25-000002 · primary_doc.xml · derivative · entry 1

Andrle Edward · CIK 0001656026 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-06-23

F1 · derivative.exercise_date: The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.

Read SEC document
June 04, 2025 Filed Jun 5, 2025 20:08 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 10,000 $0.58 $5,804.00
Disclosure

SEC source: 0001709738-25-000007 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,491

Read SEC document
June 01, 2025 Filed Jun 3, 2025 15:45 UTC
Johns Emily J.General Counsel
GrantOption to Purchase Common Stock · Derivative 500,000 $0.00 Strike: $0.61 $0.00
Disclosure

SEC source: 0002067635-25-000003 · primary_doc.xml · derivative · entry 1

Johns Emily J. · CIK 0002067635 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2035-05-31

F1 · derivative.exercise_date: 25% will vest on June 1, 2026, and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2026.

Read SEC document
May 22, 2025 Filed May 23, 2025 20:03 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 8,967 $0.62 $5,586.44
Disclosure

SEC source: 0001709738-25-000006 · primary_doc.xml · nonDerivative · entry 2

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,491

Read SEC document
May 21, 2025 Filed May 23, 2025 20:03 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 14 $0.65 $9.10
Disclosure

SEC source: 0001709738-25-000006 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 280,458

Read SEC document
May 20, 2025 Filed May 21, 2025 20:14 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 3,013 $0.66 $1,975.93
Disclosure

SEC source: 0001709738-25-000005 · primary_doc.xml · nonDerivative · entry 2

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 280,472

Read SEC document
May 19, 2025 Filed May 21, 2025 20:14 UTC
Christianson MarkBusiness Development Director
SaleCommon Stock 8,006 $0.67 $5,329.59
Disclosure

SEC source: 0001709738-25-000005 · primary_doc.xml · nonDerivative · entry 1

Christianson Mark · CIK 0001709738 · Business Development Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,485

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.